Clinical trial of the intradermal administration of hepatitis B vaccine produced at the Department of Medical Research, Myanmar

Vaccine

Volumn 20, Issue 11-12, 2002, Pages 1649-1652

  Kyi, Khin Pyone ^a   Oo, Khin May ^a   Htun, Moh Moh ^a   Tun, Win Maw ^a   Aye, Khin Khin ^a   Oo, San San ^b   Lwin, Khin Ohmar ^b   Nyunt, Sandar ^a  

^a Vaccine Production and Distribution Division ^*  (Myanmar)

^b Department of Medical Research (Lower Myanmar)   (Myanmar)

Author keywords

Hepatitis B; Intradermal; Vaccine

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOREARM; GROUPS BY AGE; HEPATITIS B; HUMAN; IMMUNOGENICITY; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MYANMAR; PAIN; PRIORITY JOURNAL; VACCINATION;

ADULT; COSTS AND COST ANALYSIS; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INJECTIONS, INTRADERMAL; MALE; MYANMAR; PAIN;

EID: 0037154710     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00468-6     Document Type: Article

References (23)

1. Human reactogenicity, safety and immunogenicity study of the hepatitis B vaccine produced at the Department of Medical Research
2. Protective immunogenicity of recombinant and DMR plasma-derived hepatitis B vaccines in adult males
3. Combined intramuscular-intradermal protocol of universal neonate hepatitis B vaccination irrespective of mothers' status of HBsAg
4. Intradermal hepatitis B virus vaccine: Immunogenicity and side effects
5. Trials of intradermal hepatitis B vaccine in Gambian children
6. Intradermal hepatitis B vaccination in a 300-bed primary hospital: Experience with a recombinant vaccine in a four dose schedule
7. The antibody response to the intradermal recombinant hepatitis B vaccine
8. Vaccination against hepatitis B virus, value of intradermal administration in dialyzed patients, nonresponsive to intramuscular approach
9. Intradermal vaccination against hepatitis B in Immanuel Hospital personal-preliminary report
10. Response to a booster 18 months after a low anti-HBs response to three doses of intradermally or intramuscularly administered recombinant hepatitis B vaccine
11. Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease
12. Intradermal vaccination against hepatitis B virus infection in an endemic area (Nigeria) two year results
13. Intradermal hepatitis B vaccination in a large hospital employee population
14. Intradermal vaccination against hepatitis B in a group of medical students
15. Comparison of intradermal and intramuscular hepatitis B vaccination in university students
16. Intradermal hepatitis B immunization with yeast-derived vaccine: Serological response by sex and age
17. Antibody response after intradermal administration of recombinant hepatitis B vaccine in children
18. Cost effectiveness of intradermal vs subcutaneous hepatitis B vaccination for the mentally handicapped
19. Effectiveness of low-dose intradermal hepatitis B vaccination: 5 Years experience of primary vaccination
20. Intradermal inoculation with heptavax-B: Immune response and histologic evaluation of injection sites
21. Summary of clinical findings on Engerix-B, a genetically engineered yeast-drived hepatitis B vaccine
22. General discussion-importance and control of hepatitis B